Patent Application Titled "Compositions And Methods For Cancer Imaging And Radiotherapy" Published Online (USPTO 20240100204).

A patent application titled "Compositions And Methods For Cancer Imaging And Radiotherapy" has been published online. The application discusses the need for improved imaging and therapeutic agents for cancer, particularly for difficult-to-treat cancers such as pancreatic cancer and glioblastoma multiforme. The invention focuses on LDLR-targeting agents that can effectively label and detect LDLR-overexpressing cancer cells, as well as provide selective radiotherapy. The application describes conjugated compounds and methods for their use in cancer imaging, diagnosis, and treatment. The invention has the potential to improve cancer detection and therapy by targeting specific receptors and minimizing side effects. [Extracted from the article]